IG
GILD icon

Ithaka Group’s Gilead Sciences GILD Stock Holding History

Ithaka Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-289,042
Closed -$27.2M – 44
2014
Q4 		$27.2M Sell
289,042
-26,440
-8% -$2.73M 4.27% 6
2014
Q3 		$33.6M Sell
315,482
-14,585
-4% -$1.43M 5.04% 3
2014
Q2 		$27.4M Buy
330,067
+39,101
+13% +$3.04M 3.97% 6
2014
Q1 		$20.6M Buy
290,966
+41,554
+17% +$3.26M 3.42% 11
2013
Q4 		$18.7M Buy
249,412
+29,163
+13% +$2.03M 3.54% 10
2013
Q3 		$13.8M Buy
220,249
+75,344
+52% +$4.5M 3.22% 11
2013
Q2 		$7.43M Buy
+144,905
New +$7.55M 2.18% 24

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Ithaka Group's GILD Position: Q1 2015 in Review

Ithaka Group sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 289,042 shares — an estimated $27.2M sold.

Ithaka Group first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $33.6M in Q3 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Ithaka Group reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Ithaka Group sold 289,042 Gilead Sciences shares in Q1 2015, an estimated $27.2M.
  • Ithaka Group first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Ithaka Group's Gilead Sciences position peaked at $33.6M in Q3 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Ithaka Group's 13F filing for Q1 2015, filed 11 May 2015.